Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	196.76	194.92	190.13	174.21	207.5	185.45
Other Revenue	-	-	0.02	0.01	1.19	0.11
Revenue	196.76	194.92	190.14	174.22	208.69	185.56
Revenue Growth (YoY)	-0.27%	2.51%	9.14%	-16.52%	12.46%	-1.35%
Cost of Revenue	46.91	45.8	49.84	33.5	36.33	35.3
Gross Profit	149.86	149.11	140.3	140.72	172.36	150.27
Selling, General & Admin	75.97	76.71	74.35	73.71	62.81	52.62
Research & Development	20.55	23.84	30.41	15.46	25.76	22.52
Other Operating Expenses	5.45	1.68	1.53	1.21	1.45	-3.25
Operating Expenses	102.97	102.96	107.08	90.28	90.34	71.56
Operating Income	46.89	46.15	33.22	50.45	82.03	78.71
Interest Expense	-0.2	-0.43	-0.65	-0.68	-0.71	-
Interest & Investment Income	4.19	6.12	10.62	16.3	1.48	2.33
Currency Exchange Gain (Loss)	-0.03	-0.03	0.12	0.49	-0.12	-
Other Non Operating Income (Expenses)	0.8	0.23	-0.25	0.42	-0.3	-0.96
EBT Excluding Unusual Items	51.64	52.04	43.06	66.97	82.38	80.09
Gain (Loss) on Sale of Investments	-5.17	-4.97	2.59	2.62	-0.79	-5.34
Gain (Loss) on Sale of Assets	-1.03	0.41	-0.01	-0.07	-0.25	-
Asset Writedown	2.73	-	-	-	-	-
Other Unusual Items	3.59	3.09	-0.23	4.53	6.54	-
Pretax Income	51.75	50.57	45.42	74.04	87.88	74.75
Income Tax Expense	6.2	6.28	6.64	9.84	11.39	11.58
Earnings From Continuing Operations	45.55	44.29	38.77	64.2	76.48	63.17
Net Income	45.55	44.29	38.77	64.2	76.48	63.17
Net Income to Common	45.55	44.29	38.77	64.2	76.48	63.17
Net Income Growth	-10.55%	14.23%	-39.60%	-16.06%	21.07%	-3.93%
Shares Outstanding (Basic)	108	108	108	102	81	81
Shares Outstanding (Diluted)	108	108	108	102	81	81
Shares Change (YoY)	0.19%	0.30%	5.70%	25.24%	0.46%	-0.23%
EPS (Basic)	0.42	0.41	0.36	0.63	0.94	0.78
EPS (Diluted)	0.42	0.41	0.36	0.63	0.94	0.78
EPS Growth	-10.72%	13.89%	-42.86%	-32.98%	20.51%	-3.70%
Free Cash Flow	-27.92	-9.12	4.15	41.46	64.68	80.43
Free Cash Flow Per Share	-0.26	-0.08	0.04	0.41	0.80	0.99
Dividend Per Share	0.320	0.320	0.200	0.750	0.900	-
Dividend Growth	-	60.00%	-73.33%	-16.67%	-	-
Gross Margin	76.16%	76.50%	73.79%	80.77%	82.59%	80.98%
Operating Margin	23.83%	23.68%	17.47%	28.96%	39.30%	42.42%
Profit Margin	23.15%	22.72%	20.39%	36.85%	36.65%	34.04%
Free Cash Flow Margin	-14.19%	-4.68%	2.18%	23.79%	30.99%	43.34%
EBITDA	68.58	65.5	49.46	64.43	96.15	-
EBITDA Margin	34.85%	33.61%	26.01%	36.98%	46.07%	-
D&A For EBITDA	21.69	19.36	16.24	13.98	14.12	-
EBIT	46.89	46.15	33.22	50.45	82.03	78.71
EBIT Margin	23.83%	23.68%	17.47%	28.96%	39.30%	42.42%
Effective Tax Rate	11.98%	12.41%	14.62%	13.29%	12.97%	15.49%
Revenue as Reported	196.76	194.92	190.14	174.22	208.69	185.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.